1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Crystal Pharmatech to Start Extensive Collaboration with BrightGene Bio-medical technology

Crystal Pharmatech Co. Ltd has reached an agreement with BrightGene Bio-medical technology Co. Ltd to provide in-depth solid state research support.

 
PRLog - Jan. 28, 2011 - Crystal Pharmatech Co. Ltd has reached an agreement with BrightGene Bio-medical technology Co. Ltd to provide in-depth solid state research support including but not limited to: salt/polymorph screening, basic physicochemical characterization, process development support including crystallization optimization, chiral resolution, and particle size analysis.  The agreement is in place for a period of one year with further agreements to be evaluated at a later date.

"This agreement is the pioneer collaboration between a dedicated solid state research company in China and a pharmaceutical company." explains Alex M. Chen, CEO of Crystal Pharmatech Co., Ltd. "A fundamental understanding of intermediate and API solid state properties is vital to delivering high quality product. We will act as the physical characterization arm for BrightGene and ensure processes maximize yield and productivity while delivering the desired API phase with optimal particle characteristics.  This agreement keeps BrightGene’s capital costs down while ensuring high product quality.  We feel this is an excellent model for many pharmaceutical companies and look forward to many future collaborations."

BrightGene Bio-medical technology Co. Ltd is a rapidly-growing China based pharmaceutical company engaged in research, development, and manufacturing of both Active Pharmaceutical Ingredients (API) and Intermediates. Their primary focus is on the high-end API market and late stage drug candidates.

Crystal Pharmatech Co., Ltd is currently the only high-quality, dedicated solid state research company based in China.  Its researchers have extensive experience with API and drug product development.  Whether you are a top-tier innovator company or a pre-emerging biotech, Crystal Pharmatech can handle all of your solid-state property needs.  It offers a full range of services from being the solid state characterization arm of your company to consultation or training on a specific issue.  

For more information, visit: http://www.crystalpharmatech.com/


About Crystal Pharmatech Co., Ltd
Crystal Pharmatech is a technology-driven china-based CRO that focuses on the specialized field of solid state information for active pharmaceutical ingredients and formulations. It helps its clients to discover and select the optimal solid phase for development as well as aid in developing the best formulation based on solid, scientific understanding. It provides its clients a complete and satisfactory solution to the problem they face instead of merely running experiments and collecting data.
   
About BrightGene Bio-medical technology Co. Ltd
BrightGene Bio-medical technology CO., Ltd is a fast-growing biopharmaceutical company that engages in the research, development and manufacturing of Active Pharmaceutical Ingredients and Intermediates with primary focus on the high-end API market and late-stage drug candidates. The Company has achieved revenue growth rate of over 100% annually since its establishment in 2001. It is now one of the most Distinguished Technology Businesses in the province of Jiangsu. It has been rewarded research grants by the Ministry of Science and Technology for innovative breakthroughs in a number of patented pharmaceutical intermediates.

# # #

Crystal Pharmatech is a technology-driven CRO that focuses on the specialized field of solid state information for active pharmaceutical ingredients and formulations.

--- End ---

Click to Share

Contact Email:
***@crystalpharmatech.com Email Verified
Source:Crystal Pharmatech
Phone:86-512-69561921
Zip:215123
Country:China
Industry:Research, Services, Industrial
Tags:crystal pharmatech, brightgene, polymorph, salt, physicochemical, crystallization, chiral, particle, pharmacy, api
Last Updated:Jan 28, 2011
Shortcut:prlog.org/11257029
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share